Journal Papers,
Abstracts, and Commentaries
| |
A WEEK-IN-REVIEW FEATURED REPORT
Effects of short-course zidovudine on the selection of
nevirapine-resistant HIV-1 in women taking single-dose nevirapine.
Micek MA, Blanco AJ, Carlsson J, et al
J Infect Dis.
2012 Apr 5.
Abstract
A Comparison of 3 Regimens to Prevent Nevirapine Resistance
Mutations in HIV-Infected Pregnant Women Receiving a Single Intrapartum Dose of
Nevirapine.
Van Dyke RB, Ngo-Giang-Huong N, Shapiro DE, et
al
Clin Infect Dis. 2011 Dec 5.
Abstract
FULL-TEXT ARTICLE
Emergence and Persistence of Minor Drug-Resistant HIV-1 Variants in Ugandan
Women after Nevirapine Single-Dose Prophylaxis.
Hauser A, Mugenyi K, Kabasinguzi R, et al
PLoS One. 2011;6(5):e20357.
Paper
FULL-TEXT ARTICLE
Detection of HIV drug resistance mutations in pregnant women receiving
single dose
Nevirapine in south India.
Jacob MS, Durairaj A, Vijayakumari J,
et al
Indian J Pathol Microbiol. 2011
April-June;54(2):359-361.
Paper
Analysis of nevirapine resistance in HIV-infected infants who received extended
nevirapine or
nevirapine/zidovudine prophylaxis.
Fogel J, Hoover DR, Sun J,
et al
AIDS. 2011 Apr
24;25(7):911-917.
Abstract
Minor drug-resistant HIV type-1 variants in breast milk and
plasma of HIV type-1-infected Ugandan women
after nevirapine single-dose prophylaxis.
Pilger D, Hauser A, Kuecherer C, Mugenyi K, et al
Antivir Ther.
2011;16(1):109-13.
Abstract
A
WEEK-IN-REVIEW-FEATURED REPORT
Slower Clearance of Nevirapine Resistant Virus in Infants Failing Extended
Nevirapine Prophylaxis
for Prevention of Mother-to Child HIV-Transmission.
Persaud D, Bedri A, Ziemniak C,
et al
AIDS Res Hum Retroviruses.
2011 Jan 18.
Abstract |
Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose
nevirapine effectively
reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi.
Farr SL, Nelson JA, Ng'ombe TJ,, et al
J Acquir Immune Defic Syndr. 2010
Aug 15;54(5):515-23
Abstract |
FULL-TEXT ARTICLE
Minor resistant variants in nevirapine-exposed infants may
predict virologic failure
on nevirapine-containing ART.
Macleod IJ, Rowley CF, Thior I, Wester
C, et al
J Clin Virol. 2010 Apr
26.
Abstract |
Nevirapine Resistance by Timing of HIV Type 1 Infection in Infants
Treated with
Single-Dose Nevirapine.
Micek MA, Blanco AJ, Beck IA,
et al
Clin Infect Dis.
2010 Apr 12
Abstract |
Detection of HIV-1-Drug-Resistance in Women Following Single-Dose-Nevirapine:
Comparison of Plasma RNA versus Cellular DNA by Consensus Sequencing and by
Oligonucleotide Ligation Assay.
Wagner TA, Kress CM, Beck I, et al
J Clin Microbiol.
2010 Feb 24
Abstract |
Addition of extended zidovudine to extended nevirapine prophylaxis reduces
nevirapine
resistance in infants who were HIV-infected in utero.
Lidström J, Li Q, Hoover DR, Kafulafula G,
et al
AIDS.
2010 Jan 28;24(3):381-6.
Abstract |
Tolerance and viral resistance after single-dose nevirapine with
tenofovir and emtricitabine to prevent
vertical transmission of HIV-1.
The TEmAA ANRS 12109 Study group.
AIDS. 2009
Mar 19.
Abstract |
Addition of extended zidovudine to extended nevirapine prophylaxis reduces
nevirapine resistance
in infants who were HIV-infected in utero.
Lidström J, Li Q, Hoover DR, et al
AIDS.
2009 Dec 5.
Abstract |
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving
pregnancy-limited
antiretroviral therapy.
Paredes R, Cheng I, Kuritzkes DR, et
al
AIDS.2009
Nov 12
Abstract |
FULL TEXT
ARTICLE
Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the
prevention of mother-to-child
HIV transmission: a randomized clinical trial.
McIntyre JA, Hopley M, Moodley D, et al
PLoS
Med. 2009 Oct;6(10):e1000172.
Paper |
Lower Risk of Resistance After Short-Course HAART Compared With
Zidovudine/Single-Dose Nevirapine
Used for Prevention of HIV-1 Mother-to-Child Transmission.
Lehman DA, Chung MH, Mabuka JM, et al
J Acquir Immune Defic Syndr.
2009 Jun 4
Abstract |
Identification of Nevirapine-Resistant HIV-1 in the Latent Reservoir
after Single-Dose Nevirapine
to Prevent Mother-to-Child Transmission of HIV-1.
Wind-Rotolo M, Durand C, Cranmer L, et al
J Infect Dis. 2009 Apr 1.
Abstract
|
Development of resistance mutations in women receiving standard
antiretroviral therapy
who received intrapartum nevirapine to prevent perinatal human
immunodeficiency virus
type
1
transmission: a substudy of pediatric AIDS clinical trials group
protocol 316.
Cunningham CK,
Chaix ML, Rekacewicz C, et al
J Infect Dis 2002 Jul 15;186(2):181-8
Abstract
Identification of the K103N resistance mutation in Ugandan women
receiving nevirapine to
prevent HIV-1 vertical transmission.
Jackson JB, Becker-Pergola G, Guay LA, et
al
AIDS 2000 Jul
28;14(11):F111-5
Abstract
Pharmacological
implications of lengthened in-utero exposure to nevirapine.
Taylor GP, Lyall EG, Back D, Ward C,
Tudor-Williams G.
Lancet 2000
Jun 17;355(9221):2134-5
Abstract
|
|
Conference
Reports, Abstracts, and Posters
| |
POSTER
Emergence and Persistence of Nevirapine-resistant HIV in Breast
Milk after Single-dose
Nevirapine Administration
S Hudelson, M McConnell, D
Bagenda, et al
(17th CROI)
PDF
Poster
Abstract
POSTER
Greater Persistence of Drug
Resistance Mutations in HIV-1 Subtype C than Other Subtypes a
mong Women Exposed to sdNVP for the PMTCT
C Yang, E Njagi, J McNicholl, et al
(17th CROI)
PDF Poster
Abstract |
|
A Phase II
Study of the Incidence of Nevirapine Resistance Mutations in HIV-infected Thai
Women Receiving a Single
Intrapartum Dose of NVP followed by a Postpartum Tail of ZDV/ddI or
ZDV/ddI/LPV/r: IMPAACT P1032
R Van Dyke, G Jourdain D Shapiro,
et al
(16 CROI)
Abstract
|
POSTER
Addition of 7 Days of Zidovudine +
Lamivudine to Peripartum Single-dose Nevirapine Effectively
Reduces Nevirapine
Resistance at 2 and 6 Weeks Post-partum in HIV-infected Mothers: Lilongwe,
Malawi
S Farr, J Nelson, T Ng'ombe, et al
(16 CROI)
PDF Poster
Abstract
|
POSTER
Development of Drug Resistance among a Cohort of HIV-infected Infants Exposed to
Nevirapine
for Prevention of
Mother-to-Child Transmission Initiating PI-based ART in South Africa
G Hunt, B Taylor, A Coovadia, et al
(16 CROI)
PDF Poster
Abstract
|
POSTER
Comparison of Nevirapine-resistant HIV-1 among Women Taking Single-dose
Nevirapine with and without
Short-course Zidovudine for PMTCT of HIV-1 in Mozambique
M Micek, A Blanco, J Carlsson, et al
(16 CROI)
PDF Poster
Abstract
|
POSTER
Predictors of Nevirapine Resistance
in Ugandan Infants Who Were HIV-infected despite
Single-dose Nevirapine Prophylaxis
J Church, A Mwath, L Guay, et al
(16 CROI)
PDF Poster
Abstract
|
Nevirapine metabolism and association with drug resistance in
breast milk and plasma
S. Kassaye , E. Lee , D. Holland, et al
(XVII
International AIDS Conference)
Abstract
|
Analysis
of NVP Resistance in Ugandan Infants Who Were HIV-infected despite
Receiving
Single-dose Nevirapine vs Single-dose NVP Plus up to 6 Weeks of Daily NVP
to Prevent HIV
Vertical Transmission
J Church, S Omer, L Guay, et
al
(15th CROI)
Abstract
|
POSTER
Analysis
of K103N-containing HIV-1 Variants in Women with HIV-1 Subtypes A,
C, and D
after Single-dose Nevirapine Using a Sensitive and Quantitative
Point Mutation Assay
T
S. Flys, S Chen, D Jones, et al
(13 CROI)
PDF
Poster
Abstract
|
Selection of Resistance Mutations in Children Receiving Prophylaxis
with Lamivudine or
Nevirapine for the Prevention of Postnatal Transmission of HIV
M Giuliano, C Galluzzo, E Germinario, et al
(12 CROI)
Abstract
|
Clonal Analysis of Drug-resistant Mutations in Plasma
and Breast Milk following
Single-dose Nevirapine
E
Lee, R Kantor, E Johnston, et al
(12 CROI)
Abstract
|
Controversies in the Use of Nevirapine for Prevention
of Mother-to-Child Transmission
J McIntyre
(12 CROI)
Abstract
|
Infant Zidovudine Prophylaxis and Emergence of Nevirapine Resistance
at 6 Weeks in
Perinatally HIV-infected Infants Exposed to Intra-partum or Newborn
Nevirapine
N
Ngo-Giang-Huong, G Jourdain, P Tungyai, et al
(12 CROI)
Abstract
|
Sensitive Drug Resistance Assays Reveal Long-term Persistence of
HIV-1 Variants with
the K103N Nevirapine-resistance Mutation in Some Women and Infants
after Single-dose
NVP: HIVNET 012
S
Eshleman, D Nissley, C Claasen, et al
(12 CROI)
Abstract
|
|
|
POSTER
Nevirapine Plasma
Concentrations Are Still Detectable after More than 2 Weeks in the
Majority of Women Receiving Single-dose NVP: Implications for
Intervention Studies
E Muro, J Droste, H ter Hofstede,
et al
(11
CROI
PDF
Poster
Abstract
|
Selection of Nevirapine Resistance (NVPR) Mutations in Ugandan Women and
Infants
Receiving NVP Prophylaxis To Prevent HIV-1 Vertical Transmission
(HIVNET-012).
(8 CROI)
Abstract |
|
Journal Papers, Abstracts,
and Commentaries
|
Perinatal
NVP Main Page
Main
New/Newsworthy
